Finance

Lists
SVE:WSE
Synthaverse SA
PLN 2.84
+0.53%
(+0.015) 1D
Oct 5, 5:00:00 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for SVE...
Open
PLN 2.85
High
PLN 2.85
Low
PLN 2.77
Mkt. cap
214.37M
Avg. vol.
37.30K
Volume
13.68K
52-wk high
PLN 4.40
52-wk low
PLN 2.60
Shares outstanding
76.02M
No. of employees
214
Open
PLN 2.85
High
PLN 2.85
Low
PLN 2.77
Mkt. cap
214.37M
Avg. vol.
37.30K
Volume
13.68K
52-wk high
PLN 4.40
52-wk low
PLN 2.60
Shares outstanding
76.02M
No. of employees
214
News stories
From web sources and news partners
Profile
Synthaverse S.A., formerly known as Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company manufactures medicinal preparations. The company's headquarters is in Lublin. Wikipedia
About Synthaverse SA
CEO-
Employees214
Founded1944
Headquarters-
SectorBiotechnology
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.79M
17.51M
13.61M
12.85M
Cost of goods sold
3.12M
8.05M
6.43M
5.40M
Cost of revenue
3.12M
8.05M
6.43M
5.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.38M
10.86M
10.25M
11.29M
Operating expense
9.07M
17.01M
7.88M
8.09M
Total operating expenses
12.20M
25.06M
14.31M
13.49M
Operating income
-7.41M
-7.55M
-701.00K
-641.00K
Other non operating income
-357.00K
64.00K
-
-1.00K
EBT including unusual items
-8.96M
-8.71M
-4.14M
-3.42M
EBT excluding unusual items
-8.96M
-8.46M
-4.18M
-3.38M
Income tax expense
-1.24M
-1.80M
-537.00K
-656.00K
Effective tax rate
13.78%
20.72%
12.96%
19.20%
Other operating expenses
689.00K
6.15M
-2.37M
-3.20M
Net income
-7.72M
-6.90M
-3.61M
-2.76M
Net profit margin
-161.27%
-39.43%
-26.50%
-21.48%
Earnings per share
-
-
-
-
Interest and investment income
-
535.00K
-
-
Interest expense
-1.20M
-1.49M
-2.58M
-3.63M
Net interest expenses
-1.20M
-956.00K
-2.58M
-3.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.20M
-5.56M
2.67M
2.74M
Gain or loss from assets sale
-
-250.00K
-
-
AI content may include mistakes. Learn more
Google apps